Eli Lilly, Incyte RA drug posts positive mid-stage data; Verastem losses surge; Boehringer strikes new tech pact;

Conversations on Twitter :

 @FierceBiotech: Protein biomarker predicts Type 2 diabetes years in advance. Story | Follow @FierceBiotech

 @JohnCFierce: Want to sell expensive cancer drugs in China? Get the middle class to buy health insurance. Story | Follow @JohnCFierce

 @RyanMFierce: Hep C pill race report 2012: $GILD, $ABT, $VRTX, others rush toward pharma gold. Report | Follow @RyanMFierce

> Eli Lilly ($LLY) and Incyte ($INCY) say their experimental rheumatoid arthritis drug baricitinib reduced symptoms in a mid-stage study, with the highest dose also reducing joint damage. Story

> Verastem ($VSTM) says its losses grew in the last quarter, primarily due to increasing R&D costs. Story

> Boehringer Ingelheim and BaroFold have struck a non-exclusive technology and commercial license option agreement in which Boehringer will acquire a laboratory-scale reactor of BaroFold's Pressure Enabled Manufacturing Technology that can also be qualified for GMP use. Release

Pharma News

@FiercePharma: $AZN's Seroquel franchise takes another hit: German court rules XR patent invalid. U.K. did already. Anyone else? More | Follow @FiercePharma

> Roche sells insurance to gin up paying customers in China. Story

> AMA lines up against pharma's pay-to-delay deals. News

> Genzyme resolves shortage of cancer drug Thyrogen. Article

> Pfizer, Protalix near Eleyso supply deal in Brazil. Report

Medical Device News

 @FierceMedDev: Medtronic gains expanded approval for ts Valiant Captivia stent graft system. More | Follow @FierceMedDev

 @MarkHFierce: Malaysia looking to beef up its medical device clinical testing capabilities. Item | Follow @MarkHFierce

 @DamianFierce: Mindray Medical is recalling anesthesia devices over a leak risk. News | Follow @DamianFierce

> FDA blocks Hospira from importing pumps. Article

> Edwards crushes Medtronic in appeals fight over heart valve patent. Story

Biomarkers News

> Biomarker tags AstraZeneca's clot buster activity in patient subgroup. Story

> Genetic mutations signpost inherited heart risk. Item

> Protein marker tags activity for GlaxoSmithKline drug in mesothelioma. More

> Fox Foundation funds BioFIND Parkinson's marker project. News

Drug Delivery News

> Injectable sponge stars and hearts deliver drugs. Story

> Optinose $2.1M grant to deliver autism treatment from the nose to the brain. Item

> Bacterial 'minicells' deliver cancer drugs straight to the target. More

> GSK, XenoPort terminate extended-release gabapentin deal. Article

And Finally… Investigators at Queen's University Belfast say they have solved the mystery behind a large set of what had been unexplainable cases of infertility. Release


Suggested Articles

UCB’s bispecific antibody recently beat Johnson & Johnson’s Stelara at clearing psoriasis symptoms, and now it has bested AbbVie’s Humira, too.

FDA staff took the action in response to cases of early growth plate closure in children on the retinoic acid receptor gamma agonist.

The CTAD presentation cleared up some questions about the data set without delivering a telling blow for either side of the debate.